Literature DB >> 27600688

Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome.

César Quiroz1, Seema Gulyani2, Wan Ruiqian2, Jordi Bonaventura1, Roy Cutler2, Virginia Pearson3, Richard P Allen3, Christopher J Earley3, Mark P Mattson2, Sergi Ferré4.   

Abstract

Deficits of sensorimotor integration with periodic limb movements during sleep (PLMS) and hyperarousal and sleep disturbances in Restless Legs Syndrome (RLS) constitute two pathophysiologically distinct but interrelated clinical phenomena, which seem to depend mostly on alterations in dopaminergic and glutamatergic neurotransmission, respectively. Brain iron deficiency is considered as a main pathogenetic mechanism in RLS. Rodents with brain iron deficiency represent a valuable pathophysiological model of RLS, although they do not display motor disturbances. Nevertheless, they develop the main neurochemical dopaminergic changes found in RLS, such as decrease in striatal dopamine D2 receptor density. On the other hand, brain iron deficient mice exhibit the characteristic pattern of hyperarousal in RLS, providing a tool to find the link between brain iron deficiency and sleep disturbances in RLS. The present study provides evidence for a role of the endogenous sleep-promoting factor adenosine. Three different experimental preparations, long-term (22 weeks) severe or moderate iron-deficient (ID) diets (3- or 7-ppm iron diet) in mice and short-term (3 weeks) severe ID diet (3-ppm iron diet) in rats, demonstrated a significant downregulation (Western blotting in mouse and radioligand binding saturation experiments in rat brain tissue) of adenosine A1 receptors (A1R) in the cortex and striatum, concomitant to striatal D2R downregulation. On the other hand, the previously reported upregulation of adenosine A2A receptors (A2AR) was only observed with severe ID in both mice and rats. The results suggest a key role for A1R downregulation in the PLMS and hyperarousal in RLS. Published by Elsevier Ltd.

Entities:  

Keywords:  Adenosine A(1) receptor; Adenosine A(2A) receptor; Brain iron deficiency; Dopamine D(2) receptor; Restless Legs Syndrome

Mesh:

Substances:

Year:  2016        PMID: 27600688      PMCID: PMC5056844          DOI: 10.1016/j.neuropharm.2016.09.002

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  44 in total

1.  A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors.

Authors:  Katerina Antoniou; Zeta Papadopoulou-Daifoti; Thomas Hyphantis; Georgia Papathanasiou; Efstathios Bekris; Marios Marselos; Leigh Panlilio; Christa E Müller; Steven R Goldberg; Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

2.  Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study.

Authors:  David Elmenhorst; Philipp T Meyer; Oliver H Winz; Andreas Matusch; Johannes Ermert; Heinz H Coenen; Radhika Basheer; Helmut L Haas; Karl Zilles; Andreas Bauer
Journal:  J Neurosci       Date:  2007-02-28       Impact factor: 6.167

Review 3.  Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission.

Authors:  David J Dooley; Charles P Taylor; Sean Donevan; Douglas Feltner
Journal:  Trends Pharmacol Sci       Date:  2007-01-10       Impact factor: 14.819

4.  Chronic sleep restriction induces long-lasting changes in adenosine and noradrenaline receptor density in the rat brain.

Authors:  Youngsoo Kim; David Elmenhorst; Robert E Strecker; Andreas Bauer; Angela Weisshaupt; Franziska Wedekind; Tina Kroll; Robert W McCarley
Journal:  J Sleep Res       Date:  2015-04-21       Impact factor: 3.981

5.  The effects of dietary iron deprivation on murine circadian sleep architecture.

Authors:  Terry Dean; Richard P Allen; Christopher P O'Donnell; Christopher J Earley
Journal:  Sleep Med       Date:  2006-11-13       Impact factor: 3.492

6.  Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model.

Authors:  Carina J Bleickardt; Tatiana M Kazdoba; Nicholas T Jones; John C Hunter; Robert A Hodgson
Journal:  Pharmacol Biochem Behav       Date:  2013-11-08       Impact factor: 3.533

7.  Increased electroencephalographic high frequencies during the sleep onset period in patients with restless legs syndrome.

Authors:  Raffaele Ferri; Filomena I I Cosentino; Mauro Manconi; Francesco Rundo; Oliviero Bruni; Marco Zucconi
Journal:  Sleep       Date:  2014-08-01       Impact factor: 5.849

Review 8.  Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).

Authors:  Christopher J Earley; James Connor; Diego Garcia-Borreguero; Peter Jenner; John Winkelman; Phyllis C Zee; Richard Allen
Journal:  Sleep Med       Date:  2014-06-16       Impact factor: 3.492

Review 9.  Regulation of transferrin function and expression: review and update.

Authors:  C N Lok; T T Loh
Journal:  Biol Signals Recept       Date:  1998 May-Jun

10.  An Adenosine-Mediated Glial-Neuronal Circuit for Homeostatic Sleep.

Authors:  Theresa E Bjorness; Nicholas Dale; Gabriel Mettlach; Alex Sonneborn; Bogachan Sahin; Allen A Fienberg; Masashi Yanagisawa; James A Bibb; Robert W Greene
Journal:  J Neurosci       Date:  2016-03-30       Impact factor: 6.167

View more
  22 in total

1.  The Adenosine Hypothesis of Restless Legs Syndrome.

Authors:  Sergi Ferré
Journal:  J Caffeine Adenosine Res       Date:  2019-03-14

2.  Sleep Medicine: Restless Legs Syndrome.

Authors:  Pradeep C Bollu; Anudeep Yelam; Mahesh M Thakkar
Journal:  Mo Med       Date:  2018 Jul-Aug

3.  Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron.

Authors:  Marla Rivera-Oliver; Estefanía Moreno; Yocasta Álvarez-Bagnarol; Christian Ayala-Santiago; Nicole Cruz-Reyes; Gian Carlo Molina-Castro; Stefan Clemens; Enric I Canela; Sergi Ferré; Vicent Casadó; Manuel Díaz-Ríos
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

4.  Targeting hypersensitive corticostriatal terminals in restless legs syndrome.

Authors:  Gabriel Yepes; Xavier Guitart; William Rea; Amy H Newman; Richard P Allen; Christopher J Earley; César Quiroz; Sergi Ferré
Journal:  Ann Neurol       Date:  2017-12-07       Impact factor: 10.422

Review 5.  Pathological overproduction: the bad side of adenosine.

Authors:  Pier Andrea Borea; Stefania Gessi; Stefania Merighi; Fabrizio Vincenzi; Katia Varani
Journal:  Br J Pharmacol       Date:  2017-03-31       Impact factor: 8.739

Review 6.  Brain-iron deficiency models of restless legs syndrome.

Authors:  Christopher J Earley; Byron C Jones; Sergi Ferré
Journal:  Exp Neurol       Date:  2022-06-30       Impact factor: 5.620

7.  Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.

Authors:  Shangru Lyu; Mark P DeAndrade; Stefan Mueller; Alexander Oksche; Arthur S Walters; Yuqing Li
Journal:  Behav Brain Res       Date:  2019-07-31       Impact factor: 3.332

Review 8.  Cannabis for Restless Legs Syndrome.

Authors:  Imad Ghorayeb
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport.

Authors:  Sergi Ferré; César Quiroz; William Rea; Xavier Guitart; Diego García-Borreguero
Journal:  Adv Pharmacol       Date:  2019-01-18

Review 10.  New Insights into the Neurobiology of Restless Legs Syndrome.

Authors:  Sergi Ferré; Diego García-Borreguero; Richard P Allen; Christopher J Earley
Journal:  Neuroscientist       Date:  2018-07-26       Impact factor: 7.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.